계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Immune-Onc Therapeutics
company
About
Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $25M
- Industries
- Biopharma,Biotechnology,Health Care,Medical,Therapeutics
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Immune-Onc Therapeutics is a newly established bio-pharmaceutical company that focuses on developing innovative therapeutic antibodies for cancer treatment. The company applies the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$32M
Immune-Onc Therapeutics has raised a total of
$32M
in funding over 2 rounds. Their latest funding was raised on
Jan 5, 2023 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 5, 2023 | Series B | $25M | 1 | — | — | Detail |
| Sep 1, 2016 | Series A | $7M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Immune-Onc Therapeutics is funded by 2 investors.
Qianzhan Investment Management
and Fame Mount Limited
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
